ES0169501022
ES0169501022
PHARMA MAR, S.A.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 221.390.000 | 174.855.000 | 26.6% |
| Cost of Revenue | 12.260.000 | 8.183.000 | 49.8% |
| Gross Profit | 209.130.000 | 166.672.000 | 25.5% |
| 149.169.000 | 160.654.000 | 7.1% | |
| Operating Income | 59.961.000 | 6.018.000 | 896.4% |
| Pretax Income | 59.651.000 | 11.985.000 | 397.7% |
| Net Income Common Stockholders | 74.986.000 | 26.125.000 | 187.0% |
| -- | -- | -- | |
| -- | -- | -- |